Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carboplatin, a platinum-based chemotherapeutic agent, exerts its cytotoxic effects primarily by targeting DNA. Its main mechanism involves the formation of covalent bonds with nucleophilic sites on DNA, most notably the N7 position of guanine bases. This interaction leads to the creation of various types of adducts, including monoadducts, intrastrand crosslinks, and interstrand crosslinks. These adducts disrupt essential cellular processes such as replication and transcription, ultimately triggering cell death in tumor cells.
Formation of covalent adducts at the N7 position of guanine bases in DNA, leading to DNA crosslinking and disruption of replication and transcription.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA crosslinking at N7 position of guanine bases.